Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 35, 2010, Pages 15553-15558

  Auf, Gregor ^a,b,c   Jabouille, Arnaud ^a,b   Guérit, Sylvaine ^a,b   Pineau, Raphaël ^b   Delugin, Maylis ^a,b   Bouchecareilh, Marion ^a,b,d   Magnin, Noël ^a,b   Favereaux, Alexandre ^b,e   Maitre, Marlène ^e   Gaiser, Timo ^f   Von Deimling, Andreas ^f,g   Czabanka, Marcus ^c   Vajkoczy, Peter ^c   Chevet, Eric ^b,d   Bikfalvi, Andreas ^a,b   Moenner, Michel ^a,b  

^a Institut National de la Santé et de la Recherche Médicale U920   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d INSERM   (France)

^e INSTITUT FRANÇOIS MAGENDIE   (France)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Mesenchymal drift; Tumor ischemia; Unfolded protein response

Indexed keywords

DECORIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX PROTEIN; OSTEONECTIN; PROTEIN IRE1; THROMBOSPONDIN 1; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CANCER INVASION; CANCER SURVIVAL; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; FETUS MEMBRANE; GLIOBLASTOMA; GROWTH RATE; HUMAN; HUMAN CELL; ISCHEMIA; MESENCHYME; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; UPREGULATION;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; ENDORIBONUCLEASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; KAPLAN-MEIERS ESTIMATE; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MICROSCOPY, VIDEO; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 77957288028     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914072107     Document Type: Article

References (45)

1. Kleihues P, et al. (2007) Glioblastoma. WHO Classification of Tumours of the Central Nervous System, eds Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Intl Agency Res Cancer, Lyon, France), pp 33-49.
2. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249-257.
3. Jain RK, et al. (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8:610-622.
4. Lee G, Zacest AC, Reilly PL (2003) Recurrent haemorrhage from a malignant brain stem glioma: A review of the mechanisms of tumoural haemorrhage. J Clin Neurosci 10:632-634.
5. de Groot JF, et al. (2010) Tumor invasion after treatment of glioblastoma with bevacizumab: Radiographic and pathologic correlation in humans and mice. Neurooncol 12:233-242.
6. Lamszus K, Kunkel P, Westphal M (2003) Invasion as limitation to anti-angiogenic glioma therapy. Acta Neurochir Suppl (Wien) 88:169-177.
7. Loges S, Mazzone M, Hohensinner P, Carmeliet P (2009) Silencing or fueling metastasis with VEGF inhibitors: Antiangiogenesis revisited. Cancer Cell 15:167-170.
8. Blouw B, et al. (2003) The hypoxic response of tumors is dependent on their microenvironment. Cancer Cell 4:133-146. (Pubitemid 37040829)
9. Du R, et al. (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13:206-220.
10. Pàez-Ribes M, et al. (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220-231.
11. Rubenstein JL, et al. (2000) Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2:306-314.
12. Saidi A, et al. (2009) Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. Int J Cancer 125:1054-1064.
13. Lamszus K, et al. (2005) Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin. Clin Cancer Res 11:4934-4940.
14. Du R, et al. (2008) Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro-oncol 10:254-264.
15. Sakariassen PO, et al. (2006) Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci USA 103:16466-16471.
16. Demuth T, et al. (2008) Glioma cells on the run - the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 9:54.
17. Almog N, et al. (2009) Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Cancer Res 69:836-844.
18. Godard S, et al. (2003) Classification of human astrocytic gliomas on the basis of gene expression: A correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 63:6613-6625.
19. Friedl P, Wolf K (2003) Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat Rev Cancer 3:362-374. (Pubitemid 37328856)
20. Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519-529.
21. Schröder M, Kaufman RJ (2005) ER stress and the unfolded protein response. Mutat Res 569:29-63.
22. Hollien J, et al. (2009) Regulated Ire1-dependent decay of messenger RNAs in mammalian cells. J Cell Biol 186:323-331.
23. Greenman C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446:153-158.
24. Drogat B, et al. (2007) IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res 67:6700-6707.
25. Winkler F, et al. (2009) Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis. Glia 57:1306-1315.
26. Hagedorn M, et al. (2005) Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci USA 102:1643-1648. (Pubitemid 40209221)
27. Shweiki D, Neeman M, Itin A, Keshet E (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA 92:768-772.
28. Ma Y, Hendershot LM (2004) The role of the unfolded protein response in tumour development: Friend or foe? Nat Rev Cancer 4:966-977.
29. Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 9:677-684.
30. Acosta-Alvear D, et al. (2007) XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. Mol Cell 27:53-66.
31. Iwakoshi NN, Lee AH, Glimcher LH (2003) The X-box binding protein-1 transcription factor is required for plasma cell differentiation and the unfolded protein response. Immunol Rev 194:29-38. (Pubitemid 36886426)
32. Lee AH, Iwakoshi NN, Anderson KC, Glimcher LH (2003) Proteasome inhibitors disrupt the unfolded protein response in myeloma cells. Proc Natl Acad Sci USA 100:9946-9951.
33. Nawrocki ST, et al. (2005) Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis. Cancer Res 65:11658-11666.
34. Rahmani M, et al. (2007) The kinase inhibitor sorafenib induces cell death through a process involving inductionof endoplasmic reticulumstress. Mol Cell Biol 27:5499-5513.
35. Giese A, et al. (1996) Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67:275-282.
36. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36:1046-1069. (Pubitemid 38501557)
37. Tso CL, et al. (2006) Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 4:607-619.
38. Lipson KL, et al. (2006) Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab 4:245-254.
39. Schubert U, et al. (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770-774.
40. Brulliard M, et al. (2007) Nonrandom variations in human cancer ESTs indicate that mRNA heterogeneity increases during carcinogenesis. Proc Natl Acad Sci USA 104:7522-7527.
41. Koumenis C, Wouters BG (2006) "Translating" tumor hypoxia: Unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol Cancer Res 4:423-436.
42. Bennewith KL, et al. (2009) The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth. Cancer Res 69:775-784.
43. Czabanka M, Vinci M, Heppner F, Ullrich A, Vajkoczy P (2009) Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy. Int J Cancer 124:1293-1300.
44. Vajkoczy P, Schilling L, Ullrich A, Schmiedek P, Menger MD (1998) Characterization of angiogenesis and microcirculation of high-grade glioma: An intravitalmultifluorescence microscopic approach inthe athymicnudemouse. J Cereb Blood Flow Metab 18:510-520. (Pubitemid 28213535)
45. Gentleman RC, et al. (2004) Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5:R80.